(Q37953767)

25 August 2017

title

Cardiomyocyte calcineurin signaling in subcellular domains: from the sarcolemma to the nucleus and beyond (English)

1 reference

25 August 2017

Joerg Heineke

1

1 reference

25 August 2017

Oliver Ritter

series ordinal

2

1 reference

25 August 2017

language of work or name

1 reference

29 October 2011

1 reference

Journal of Molecular and Cellular Cardiology

25 August 2017

published in

1 reference

25 August 2017

volume

52

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

62-73

1 reference

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Structure and expression of two isoforms of the murine calmodulin-dependent protein phosphatase regulatory subunit (calcineurin B)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcineurin and hypertrophic heart disease: novel insights and remaining questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Targeted proteolysis sustains calcineurin activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcineurin and human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcineurin in human heart hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Transcriptional regulation by calcium, calcineurin, and NFAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcium-calcineurin signaling in the regulation of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

CIB1 is a regulator of pathological cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Heart-specific deletion of CnB1 reveals multiple mechanisms whereby calcineurin regulates cardiac growth and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Cellular basis of abnormal calcium transients of failing human ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Dichotomy of Ca2+ in the heart: contraction versus intracellular signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Endothelin-1-stimulated InsP3-induced Ca2+ release is a nexus for hypertrophic signaling in cardiac myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Hypertrophy of the heart: a new therapeutic target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calsarcins, a novel family of sarcomeric calcineurin-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Activity-dependent nuclear translocation and intranuclear distribution of NFATc in adult skeletal muscle fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Post-translational regulation of calsarcin-1 during pressure overload-induced cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

MLP: a stress sensor goes nuclear.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Cardiac dysfunction and heart failure are associated with abnormalities in the subcellular distribution and amounts of oligomeric muscle LIM protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Myocyte remodeling in response to hypertrophic stimuli requires nucleocytoplasmic shuttling of muscle LIM protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

PKC-alpha regulates cardiac contractility and propensity toward heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcineurin protects the heart in a murine model of dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Lmcd1/Dyxin, a novel Z-disc associated LIM protein, mediates cardiac hypertrophy in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Structural and biochemical characterization of CIB1 delineates a new family of EF-hand-containing proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Cib2 binds integrin alpha7Bbeta1D and is reduced in laminin alpha2 chain-deficient muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Molecular characterization of the sheep CIB1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcium-and integrin-binding protein regulates focal adhesion kinase activity during platelet spreading on immobilized fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Association of protein kinase A and protein phosphatase 2B with a common anchoring protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

AKAP79/150 anchoring of calcineurin controls neuronal L-type Ca2+ channel activity and nuclear signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The L-type calcium channel in the heart: the beat goes on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Ca(2+) signaling domains responsible for cardiac hypertrophy and arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Expression of T-type Ca(2+) channels in ventricular cells from hypertrophied rat hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The real estate of cardiac signaling: location, location, location

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Cardiac excitation-contraction coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Electrical remodeling in pressure-overload cardiac hypertrophy: role of calcineurin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

A Ca(2+)-dependent transgenic model of cardiac hypertrophy: A role for protein kinase Calpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Prolactin secretion and intracellular Ca(2+) change in rat lactotroph subpopulations stimulated by thyrotropin-releasing hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Continuous blockade of L-type Ca2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Cardiac T-type Ca(2+) channels in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Ca2+ influx through T- and L-type Ca2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

TRPC channels as effectors of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The diacylgylcerol-sensitive TRPC3/6/7 subfamily of cation channels: functional characterization and physiological relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Functional interaction between InsP3 receptors and store-operated Htrp3 channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Upregulation of TRPC1 in the development of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Cardiac-specific overexpression of a high Ca2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

TRPC channels are necessary mediators of pathologic cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

TRPC1 channels are critical for hypertrophic signaling in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Sarcoplasmic reticulum and nuclear envelope are one highly interconnected Ca2+ store throughout cardiac myocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Intracellular devastation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Inositol trisphosphate and calcium signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

IP3 receptor-dependent Ca2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The IP3 receptor regulates cardiac hypertrophy in response to select stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The STIM/Orai coupling machinery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Essential role of STIM1 in the development of cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Critical role for stromal interaction molecule 1 in cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Modification by nuclear export?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The nuclear pore complex as a transport machine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Characterization of Ran-driven cargo transport and the RanGTPase system by kinetic measurements and computer simulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Nuclear targeting signal recognition: a key control point in nuclear transport?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Nucleocytoplasmic transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Nucleocytoplasmic transport: signals, mechanisms and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Mechanisms of Receptor-Mediated Nuclear Import and Nuclear Export

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

NF-AT activation requires suppression of Crm1-dependent export by calcineurin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Low affinity Ca2+-binding sites of calcineurin B mediate conformational changes in calcineurin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Temporal changes in atrial EC-coupling during prolonged stimulation with endothelin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Endothelin-1 enhances nuclear Ca2+ transients in atrial myocytes through Ins(1,4,5)P3-dependent Ca2+ release from perinuclear Ca2+ stores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

IP3-dependent nuclear Ca2+ signalling in the mammalian heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca(2+)-dependent signaling cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

The calcineurin-myocyte enhancer factor 2c pathway mediates cardiac hypertrophy induced by endoplasmic reticulum stress in neonatal rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Calreticulin is essential for cardiac development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Cardiac-specific expression of calcineurin reverses embryonic lethality in calreticulin-deficient mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Identification of two calcineurin B-binding proteins: tubulin and heat shock protein 60.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

beta-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.10.018

10.1016/J.YJMCC.2011.10.018

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference